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Abstract
Low cost reduction of morbidity in lymphoedema is an essential goal in the management of
lymphatic filariasis. This review emphasises the role of movement and elevation, and refers to the
literature on the effects of these on the venous and lymphatic system. The patient with
lymphoedema becomes increasingly immobile and the affected limb is often in a permanently
dependent position causing venous hypertension and resultant overloading of the failing lymphatics.
The evidence that breathing exercises are important for reducing venous hypertension and
inducing lymphatic flow is discussed.
The contribution of a damaged epidermis to lymphatic failure is emphasised. Loss of barrier
function encourages penetration of bacteria and stimulates repair mechanisms that generate
cytokines, which, in turn lead to inflammation. Management programmes that improve the health
of the epidermis play a part in reducing lymphatic load.
In taking morbidity management of lymphoedema into the general health services there are benefits
in promoting skin hygiene and self-help regimes that can ameliorate many diseases along with
lymphoedema.
Background
To alleviate and prevent both the suffering and disability
of lymphoedema is a principal goal of the Global Alliance
for the Elimination of Lymphatic Filariasis http://
www.filariasis.org/. Although filariasis is believed to be re-
sponsible for some 40 million cases of lymphoedema, in
countries where filariasis is not seen, cancer and its man-
agement by surgery or radiotherapy is one dominant
cause and the failure of the venous system, especially in
the lower leg, is another.
The field of lymphatic filariasis has drawn special atten-
tion to recurrent inflammatory episodes as a leading cause
of morbidity in this tropical disease. It is however worth-
while looking at some of the statistics recently published
from the City of London [1], which may shed new light on
lymphatic filariasis in the context of lymphoedema in
general. Eight hundred and twenty three patients were
identified from a population of 619,000 (1.33 per 1,000)
with the prevalence rising to 0.5% in those more than 65
years old. 37% had experienced acute inflammatory epi-
sodes and 10% had experienced a medical admission for
their swelling, with a mean in-patient stay of 11.7 days. In
this population neither lymphatic filariasis nor cancer
were to blame.
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This review of lymphoedema management is written for
the reader familiar with filariasis but unfamiliar with the
literature and the management of lymphoedema in gener-
al. It focuses on self-help and will not describe the treat-
ments such as bandaging and hosiery, which are
expensive skills largely unavailable in the tropics.
Although there are no Cochrane reviews in the field of
lymphoedema management, this article discusses some of
the evidence base for focussing on the venous system and
on the health of the epidermis.
A theme that increasingly pervades the lymphoedema lit-
erature is that one cannot separate lymphatic failure from
venous failure whatsoever its cause. Furthermore, there
are elements of management, such as elevation and ankle
movement, that are especially valuable for venous disease
which are self-help measures for lymphoedema that are
potentially sustainable at low cost.
Venous failure and its role in lymphatic failure
The normal lymphatic system is a network of lymphatics
in the upper dermis, which preferentially drains into and
along low resistance preferential lymphatic trunks leading
directly to the lymph nodes. In lymphatic filariasis the
main lymphatic channels become dilated and flow is im-
paired. The network of peripheral lymphatics in the skin
becomes a 'safety valve' and acts as a conduit through the
skin until healthy lymphatic trunks are found proximally
to the damaged vessels. This 'safety valve' is a secondary
system which fails if overloaded by a failing venous sys-
tem or by the demands of a damaged epidermis.
The human upright posture encourages blood to collect in
the veins of the leg, and humans alone commonly suffer
from varicose veins and venous ulceration. The veins of
the leg are emptied by elevation and by movement of the
ankle, which results in compression of veins by leg mus-
cles. Blood flow away from the legs into the chest is en-
couraged by the lowering of venous pressure in the thorax
consequent on breathing effectively. The venous system of
the legs when overloaded leaks blood contents into the
tissues, and, in all who are immobile for a prolonged pe-
riod, such as when sitting on a long distance flight, the
veins are overfilled and oedema results. This is usually
compensated by a healthy lymphatic system. It is a feature
of chronic lymphatic failure that the limb becomes heavy
and stiff and this immobilises the limb in a dependent po-
sition and encourages such venous failure. A further con-
sequence of venous failure is the growth of new and leaky
capillaries in the dermis, which in the immobile limb fur-
ther aggravate the oedema. Persons affected by lym-
phoedema need instructions on how to maintain venous
flow and thus to prevent overloading of the venous sys-
tem.
Venous hypertension in lymphoedema
Venous hypertension is a coexisting feature of lym-
phoedema. Kim et al., [2] showed venous insufficiency in
all 41 patients in their series with lymphoedema. All pa-
tients had increased venous pressure and volume with a
decreased ejection fraction, all of which were proportional
to the size of the swollen leg.
Increased blood flow has been recorded in post mastecto-
my lymphoedema [3,4]. This was thought to worsen the
oedema present. Jacobsson [5] using radioactive isotope
clearance showed a 42% increase in blood flow in 25 such
arms. An increase in arterial flow that increases venous
filling and causes venous hypertension was postulated.
Svensson [6] noted that 70% of post mastectomy lym-
phoedema patients had abnormal arm venous outflow.
Solti [7] suggested that the increased blood flow through
the arm together with arteriovenous shunting caused by
angiogenesis in lymphoedematous arms may lead to in-
creased venous pressure. Mayall of Brazil and his co-work-
ers have termed the condition the Hyperostomy
Syndrome following an initial description by Pratesi in
1952 [8].
Evidence exists therefore, to associate the presence of ve-
nous hypertension with lymphoedema. That venous hy-
pertension can cause changes in lymph flow has been
shown in a number of studies.
Chen et al., [9] looked at the effect of increasing venous
pressure on immediate changes in lymph flow in the dog
paw. They noted an increase in lymph flow on average 5.3
minutes after pressure elevation. Impaired lymph trans-
port secondary to venous thrombosis has been shown in
at least two studies [10,11].
A recent study of warming the skin, which is one treat-
ment of lymphoedema, has found a significantly im-
proved venous flow in healthy patients and to have no
effect on lymph flow itself. The authors concluded that if
thermal therapy has a salutary benefit on lymphoedema,
then it must be operating through some other physiologic
mechanism, perhaps involving greater venous return [12].
The accumulation and reduced clearance of inflammatory
mediators in venous failure is well known [13] and it is
the basis of the Matrix Trapping Theory [14] put forward
as a cause of skin pathology induced by venous hyperten-
sion. Hence it can be concluded that chronic venous hy-
pertension is a feature of lymphoedema and can cause
overload of lymphatics through a direct effect of increased
capillary filtration and inflammation.Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/4
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Evidence of Angiogenesis and Leakage in Lymphoedema
Casley-Smith [15] described increased blood vessel vol-
ume (0.009 ml/cm3 to 0.2 ml/cm3) in the deep fascia of
experimental and congenital canine lymphoedema mod-
els. Snowden and Hanmerberg [16] demonstrated this us-
ing angiography in a filarial canine model.
Angiogenesis has also been widely observed in human
lymphoedema. Histologically it is seen in the upper der-
mis, where in normal skin a mobile fluid compartment of
tissue fluid has been shown to exist [17,18]. The venules
seen are thick walled, extended and tortuous. Roberts et
al., [19] noticed an increase in the number of sub papil-
lary capillaries in a series of 15 post mastectomy patients
– this resulted in a constant capillary density despite a
14% increase in cutaneous area, strongly suggesting that
neovascularization had occurred. This was confirmed by
Mellors et al. [20].
It is well known that the new vessels of the capillary bed
have an increase in permeability. The explanations for this
include the leaky structure of new vessels and release of in-
flammatory mediators, which range from histamine to
Vascular Endothelial Growth Factor (VEGF, initially called
Vascular Permeability Factor or VPF) which is, as an in-
ducer of permeability, up to 5000 times as potent as his-
tamine [21]. Plasma levels of VEGF [22] and VEGF
production are higher in patients with venous hyperten-
sion [13]. VEGF plays a fundamental role in the growth
and differentiation of vascular and lymphatic endothelial
cells. The VEGF family consists of VEGF-A, B, C and D
[23]. VEGF-C and D both act on VEGFR-3 (vascular en-
dothelial growth factor receptor 3), which is a receptor for
tyrosine kinase selectively expressed on lymphatic en-
dothelium. Familial Milroy's lymphoedema has recently
been attributed to mutations of the VEGFR-3 gene, which
leads to disturbed transduction of the receptor. The epi-
dermis has been found to be the likely source of VEGF
[24]. It is produced in response to any damage leading to
hyper-proliferation, including one of dermatology's fa-
vourite tools, (and the cause of sunburn), ultraviolet B ir-
radiation [25].
Angiogenesis could result from the failure of clearance of
angiogenic factors such as normal metabolites, inflamma-
tory agents and growth factors (including VEGF). The key
point is that angiogenesis, however it is initiated, does ex-
ist in lymphoedema and may lead to increased venous hy-
pertension and lymphatic overload in lymphatic disease
through a number of mechanisms.
Breathing and Lymphatic Failure
Breathing exercises have been used as a standard compo-
nent of lymphoedema management known as complex
decongestive physiotherapy (CDP). The rationale for this
is that the main lymphatic trunks lead to the thoracic duct
through which their contents empty into the large veins
above the level of the heart. Unless the main lymphatic
trunks become emptied, they act as a static reservoir into
which the peripheral lymphatics drain with difficulty.
The clearance of central lymphatics is essential before pe-
ripheral manoeuvres are taken to increase lymphatic
drainage. The dangers of trying to clear peripheral fluid
before clearing central drainage routes was illustrated by
Boris [26] who showed a significant increase of genital
oedema (43% versus 3%) following the use of compres-
sion pumps for the lower limb. Emptying of the lymphatic
system into the venous system requires that the pressure
in the latter is lowered, increased venous pressure causes
an increase in thoracic duct pressure as shown in sheep by
Gabel and Drake [27].
Severe oedema in the newborn has been attributed to lym-
phatic failure consequent on elevation of venous pressure
impeding lymph flow in a thoracic duct [28,29]. A rise in
central venous pressure of 4 mm of mercury was sufficient
to cause oedema in one study [30].
Breathing acts by increasing flow from the lymphatic sys-
tem into the venous system through the thoracic duct.
Schad et al., [31] found increased thoracic duct flow dur-
ing hyperventilation in anaesthetized dogs, while opening
the thoracic cavity decreased intrathoracic pressure, and as
a result, decreased flow through the thoracic duct. These
authors suggested that during inspiration there is a drop
in intrathoracic pressure and an increase in intra-abdomi-
nal pressure as the diaphragm pushes down, with conse-
quent movement of lymph from the abdominal to the
thoracic cavity. During expiration they suggested that the
increase in intrathoracic pressure causes lymph to be ex-
pelled through the thoracic duct into the upper thorax.
Further evidence comes from Dery et al., [32] who noted
that closed thorax compression on mice can result in
lymph uptake from distant parts of the body. That breath-
ing (hyperventilation) has an effect on the lymphatics of
the skin has been demonstrated by Allegra et al., [33] in
both primary lymphoedema and in patients with chronic
venous insufficiency. Using a Servo Nulling system, a
counter pressure pump and a pressure transducer, hyper-
ventilation was found to lower lymphatic pressure in the
skin by approximately 50%.
It was Walker and Pickard [34] who demonstrated that
deep inspiration dropped the pressure in the inferior vena
cava immediately above the diaphragm. It is interesting to
note that an effective form of breathing used for lym-
phoedema patients involves taking a deep breath through
the nose, holding the breath and then a long slow phase
of breathing out through the mouth. It is a system ofFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/4
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breathing used by many traditional systems of medicine
especially in Asia [35].
Movement in Lymphatic Failure
Movement increases both blood flow and lymph flow
through the limbs. Small amplitude movements can pro-
duce these effects, and, in lymphoedema, are better than
vigorous exercise, as exercise can increase blood flow and
tissue fluid formation in the limb.
Movement can improve lymph flow through 3 possible
mechanisms:
1. Increased uptake by initial lymphatics due to increased
tissue hydrostatic pressure variations.
2. Increased pumping of lymphatics due to smooth mus-
cle contraction in collecting lymphatics.
3. Emptying the venous system and reducing overload of
the failing lymphatics and allowing them to recover their
function.
Movement at the ankle joint in particular has been inves-
tigated. Mortimer et al., [36] noted increased radioisotope
clearance from the lymphatics of the lower limb with even
small amplitude ankle movements. Godoy and Godoy
[38] in six patients showed a change in the fluid volume
of the leg of only 160 ml on elevation but a volume
change of 830 ml after passive extension and flexion of a
foot, suggesting that even passive movement of the foot
can cause significant volume change in the lower limb.
However, patients with lymphoedematous limbs typically
have poor mobility of the affected limb. Andrade et al.,
[37] reviewed the literature and compared ankle mobility
in patients (120 limbs) with lymphoedema with that in
22 normal volunteers and found the range of movement
between ankle flexion and extension was about halved
(normal 61.1%, lymphoedema patients 34%).
The literature on the role of movement and exercise on the
management of post-mastectomy lymphoedema has been
reviewed by Bingham [39].
Movement is known to affect the venous system. Much of
the evidence that movement reduces venous hypertension
comes from studies of patients with leg ulcers. Reduced
ankle mobility has been shown to be a risk factor for poor
ulcer healing. Barwell et al., [40] showed that chronic ve-
nous ulcers were slower to heal in patients with reduced
ankle mobility – 13% of ulcers healed in patients with less
than 35° ankle mobility, whereas 60% of ulcers healed in
patients with greater than 35° of mobility. Similar find-
ings were observed by Doherty et al., [41] and Brooks [42]
who found decreased recurrence of venous ulceration in
legs of patients with full ankle movement.
More direct studies looking at the venous system have
been done as early as 1965. Daly et al., [43] noted that a
passive pumping motion of the legs decreases the venous
pressure. Furthermore, Gardner [44] observed in dog and
sheep models that simple dorsiflexion of the ankle joint
leads to the emptying of foot veins, and suggests that the
venous system is most efficient in pumping venous blood
back to the heart during normal walking. In lymphoede-
ma there is a restriction of ankle movement. Kigler et al.,
[45] studied the effect of joint restriction as a result of
wearing a limb cast. They measured peripheral venous
pressure and found that an actual reduction of venous
pressure in the dependent limb was reduced in limbs with
restricted joint mobility.
Hence it can be concluded that movement is essential in
order to drive blood through the veins out of the swollen
limb, and, in order to promote both the normal function
of healthy lymphatics and to relieve the overload on a fail-
ing lymphatic system. Continuous low amplitude ankle
movements are extremely effective in doing this.
Limb Elevation and Lymphatic Failure
To the encouragement of movement for swollen limbs
should be added exhortation to elevate. It is common
sense that fluid flow through any tissue plane will be in-
fluenced by gravitational effects. However, the key point
made here is that the main influence of gravity is on ve-
nous flow rather than lymphatic flow.
The significant effect of elevation on the venous system
has long been known in the field of venous ulcer care. Pa-
tients have long been told to elevate their limbs as much
as is reasonably possible, with healing being facilitated by
the degree of elevation of the limb [46]. Indeed Abu-Own
et al., [47] found that elevation of the leg 30 cm above
heart level for 30 minutes, 2 or 4 times a day, reduced
oedema and improved cutaneous microcirculation in
many patients with chronic venous disease.
Pippard and Roddie [48] found that gravitational changes
influence venous pressure but not the pressure within ad-
jacent lymphatics of the hind limb of the sheep when tilt-
ed on a tilt table. This suggests that limb elevation serves
mainly to increase venous return to the heart and reduce
venous pooling of the lower limb, thus reducing venous
pressure in the lower limb rather than directly increasing
afferent lymphatic flow. This has clear implications in the
reduction of venous pressure of the lymphoedematous
limb.Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/4
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Swedborg et al., [49] found that elevation effectively re-
duced the volume of control and lymphoedematous arms
of patients suffering from post-mastectomy lymphoede-
ma. They state that elevation is thought to act mainly by
decreasing the hydrostatic pressure gradient from the ve-
nous system to the tissues. This reduced the leakage of
proteins and fluids from the vascular system. They also
concluded that there was a limited effect of gravity on the
lymphatics themselves.
The Skin Barrier Function and Lymphoedema
Another important low-cost intervention that should be
considered for the management of lymphoedema is that
of maintaining the integrity of the epidermis by washing
and emollients. One of the most important qualities of
the skin is its ability to form a barrier within the epidermis
preventing access of potentially harmful agents into the
skin while at the same time preventing excess loss of fluid
from the skin. Managing this barrier function takes prece-
dence in all dermatological therapies and especially those
which prevent penetration of bacteria through the skin.
Most episodes of inflammation in lymphoedema were
blamed by early investigators on recurrent streptococcal
infections [50]. This is still the most important causative
organism but it is not the only cause of inflammation,
since we now know that mediators of inflammation such
as cytokines can be released by many triggers. Patients de-
velop a high fever, and increased redness, swelling and
pain in the tissues. This has been termed dermatolym-
phangioadenitis (DLA). Doubts have been raised as to
whether bacterial infection is the whole story. The epi-
sodes can regress within two days spontaneously and the
'devastating flesh eating responses' of contemporary strep-
tococcal infections are very rarely seen in these lym-
phoedematous limbs. Control trials comparing the effects
of long term antibiotics to simple washing [51] have
shown that washing alone may decrease the number of in-
flammatory episodes per annum. Shenoy et al., [52] also
found that neither DEC nor antibiotics altered DLA attack
frequency in their study of 65 patients with filarial lym-
phoedema. They found that 'simple hygienic measures
combined with good foot care and local antibiotics/fun-
gal cream when required were effective at reducing the
number of DLA attacks'. Similarly the experience of Drey-
er et al., [53] in Brazil suggests that simple hygiene can
protect against infections.
Pani and Srividya [54] found that the frequency of inflam-
matory episodes correlated positively with the progres-
sion through the grades of lymphoedema. Since recurrent
inflammatory episodes are a common complication of
lymphoedema and seem to exacerbate the condition fur-
ther, it seems reasonable to suppose that they cause over-
load of the lymphatic system.
In the developed world most practitioners managing post-
mastectomy lymphoedema, or lymphoedema of the leg
due to venous disease, recognise that inflammation need
not be due to bacteria, and indeed we suggest that not all
cases of DLA are caused by infection and that simple care
of the skin may reduce the inflammatory mediators pro-
duced as a result of any kind of damage to the epidermis.
It is only during the last decade that the skin has been dis-
covered to be a rich factory of cytokines and growth fac-
tors. It produces very little of these at rest and in good
health with an intact barrier function, but they are mas-
sively produced when the skin is injured and during the
process of repair. Much of the effect of the release of such
agents is to increase vascular permeability and adhesion
of white cells to the vascular endothelium in the dermis.
The epidermis is a reservoir of large quantities of IL-1 and
other cytokines like TNF made in response to irritation
and secreted into the dermis. Olszewski et al., [55]
showed the accumulation of several immune proteins and
cytokines in filarial lymphoedema, suggesting ongoing in-
flammatory responses, despite the lack of overt dermatitis.
These proteins, of which interleukin-1 is probably the
most important, accumulate in the interstitium due to
poor lymph clearance in the limb, and may cause DLA ep-
isodes in absence of infection. Importantly, Foldi [56]
found recurrent DLA attacks were nearly eliminated in
post mastectomy lymphoedema patients treated with
Complex Decongestive Physiotherapy (CDP) which in-
cluded skin care with washing and emollients, but did not
include antibiotics. This suggests that reduction of oede-
ma through improved lymphatic drainage can clear in-
flammatory mediators. Interestingly, systemic symptoms
of DLA have been observed in some patients following in-
itiation of CDP with no preceding signs of infection and
may be caused by the release of accumulated inflammato-
ry proteins from the lymphoedematous limb into tissue
both locally and directly above the swollen portion of the
limb or systemically throughout the body. Foldi et al.,
[57] also found a decrease in expression of pro-inflamma-
tory genes after CDP, suggesting that CDP affects the in-
flammatory process in a fundamental way
Studies of skin integrity include a number of interventions
that adversely affect the barrier function of the skin that
can be remedied by the use of emollients:
1. Removal of surface fats by acetone/alcohol or excessive
washing with alkaline soaps
2. High turnover states of the epidermis as may be seen in
psoriasis, nutritional deficiency diseases and electrolyte
disturbancesFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/4
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3. Sellotape stripping of surface layers of the skin
In addition to the above, skin barrier function correlates
with a low pH, the acid mantle of the skin. Pre-antibiotic
studies by Sulzberger and Baer [58] showed that heavy
contamination by a wide variety of organisms only pro-
duced inflammation responses if the barrier function of
the skin was first impaired. Studies in IL-1 and TNF recep-
tor deficient mice have recently shown a clear relationship
between the induction of cytokines within the epidermis
and loss of barrier function [59]. The IL-1 receptor defi-
cient mice had accelerated barrier function recovery fol-
lowing barrier disruption, suggesting that the increase in
IL-1 following barrier disruption normally delays compo-
nents of the repair response. The relationship between the
recovery of barrier function and decreased production of
inflammatory cytokines, prostaglandins and other in-
flammatory mediators by the epidermis, including VEGF,
in response to skin care products deserves further study.
The high mast cell content of lymphoedematous tissue,
first shown more than a century ago by Ehrlich, merits re-
examination in view of the fact that mast cells are the rich-
est source of histamine which acts through H1 and H2 re-
ceptors on cells. Contemporary studies on Keratinocytes
have shown that blocking such H1 and H2 receptors ac-
celerates skin barrier repair and prevents epidermal hyper-
plasia [60].
Thus there is currently a view of skin care procedures
which recognises the existence of sub-clinical vulnerabili-
ty of the skin due to the above and the possibility of re-
storing the barrier function and other aspects of skin
health by simple procedures such as washing and emol-
lients. They are already the focus of study by industries
manufacturing cosmetics, soaps and laundry products.
Against the background of the eczematous changes that
occur in venous disease and the gross warty changes that
are seen in lymphoedema, not withstanding the deep
crevices and the effects of fungal infections, there is clearly
potential for barrier breakdown and enhanced production
of inflammatory mediators.
Consequently, there are procedures widely used to reduce
such eczematous/dermatitic changes, including the wash-
ing away of debris and crusts, the replacement of skin sur-
face natural emollients by emollient substitutes and the
use of anti-fungals.
A number of emollients have been suggested for recovery
of skin barrier function – lanolin, mineral oil, vegetable
oil and petrolatum.
The main functions of an emollient are [61]:
1. Water absorption by the epidermis. This smoothes the
skin surface, allowing minor fissures and cracks to close
and thus improving barrier function. Some emollients, for
example, hold up to twice their own weight in water and
hold moisture in the skin.
2. Reduced loss of water from the epidermis. Thus some
emollients protect the skin and reduce trans-epidermal
water loss by up to 30%.
A strong case can be made for the study of traditional
soaps and emollients, such as the coconut oil habitually
used in Tanzania, to seek whether they have similar prop-
erties to the above. Some are known to have useful prop-
erties such as antisepsis. At least 300 traditional plant
based soaps have been identified and they have the advan-
tage of being locally available at low cost as well as a sus-
tainable source of supply (Burford and Ryan, in
preparation).
The second important component of skin care is bathing.
Emollients can be used as a soap or after a bath when the
skin is still wet and water will be trapped. There is no con-
sensus on the frequency of bathing or on the mode of
bathing (shower versus bath tub) in the treatment of dry,
damaged skin – but a common view is that super hydra-
tion of the skin is important and compliments emollient
use [62]. Dermatologists and the nursing profession em-
phasise the damage done by over washing such as pre-sur-
gical 'scrubbing'. The minimum length of bathing has
been suggested to be 10 minutes by Brown et al., [63] who
found that this significantly improved dry feet over a peri-
od of 2 weeks, and Hardy [64] who found a 10 minute
soak daily significantly improved the skin condition of 15
institutionalised elders.
Warm Water versus Cold Water
There are no clear pointers as to the advantages of using
hot or cold water. The optimum temperature for most bi-
ological systems in the human is 37°C. The skin of pe-
ripheries is adapted for a cooler metabolism. Mortimer
and Ryan (unpublished studies) have shown that warmth
increases the clearance of technesium colloid from the
skin by the lymphatic system. Shimotoyodone et al., [65]
used topical warming 40–45°C, for 2 minutes only, to
supplement massage of the gingiva and clearance of C14
methylated albumin. Cool water has no such effect. Oh-
kuma [66] has also found that the effects of vibration on
lymphatic flow are enhanced by warming. There have
been fashions in the use of heating or cooling for inflam-
mation and there has been recent re-emphasis of the fact
that keeping patients warm during surgery helps them to
heal [67]. It has been shown that epidermal repair is de-
layed by the use of cold water and it is relevant that the re-
moval of fibrosis by collagenases requires an optimumFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/4
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temperature in the region of 37°C [68]. Chen et al., [69]
have shown that warming attenuates protein micro-vascu-
lar leakage through a mechanism involving heat shock
proteins.
It is the view of the authors that the use of cold water for
washing/bathing in those with lymphoedema should be
discouraged and water that is fit for drinking, and that has
been cooled after boiling (at just above body tempera-
ture) should be used.
The Epidermis and Skin Infection
In arguing that washing with emollients restores the skin
to health and is a necessary resource for the management
of lymphoedema, one notes that in the field of wound
healing simple tap water for washing a wound has, in
some centres, replaced antibiotics and antiseptics. This
also draws attention to the barrier function of the skin and
the importance of its breakdown in determining clinical
infection, as already explained above, when describing the
pre-antibiotic studies by Sulzberger and Baer [58] and
others. Also in the days before effective anti-fungals there
were studies of skin vulnerability predisposing to infec-
tion.
Baer and Rosenthal [70] attempted to infect 150 young
adults by bathing for 30 minutes in footbaths containing
Trichophyton rubrum or T mentagrophytes but none became
infected. By producing inflammatory changes in the skin
using croton oil and cantharidin, 10 out of 33 persons de-
veloped transient asymptomatic infection. Persons who
developed blisters were more likely to develop active dis-
ease. Thus 20 of 71 persons had clinical infection at one
to four weeks after developing blisters. Five persons took
three months to develop active disease.
The part played by trauma and the degree of preceding
damage to the skin has long been shown to be an impor-
tant factor in the development of fungus infection. Kogoj
(quoted by Aravijskij, [71]) showed that trauma to the
skin of guinea pigs encouraged active disease following
the intracardiac injection of fungi. Aravijskij describes a
surgeon in whom control of fungus of the hands, by usu-
ally effective therapy, only occurred after scrubbing up re-
gimes had been less traumatic.
Conditions such as venous disease or lymphoedema pre-
dispose to infections of the skin. Andriasian, via a person-
al communication reported in [72], found that 76% of
117 patients suffering from venous disorders of the legs
were suffering from epidermophytosis of the soles. Out of
143 patients with varicose veins, 73.4% were suffering
from epidermophytosis of the soles and 90% of patients
with arterial disease were suffering from epidermophyto-
sis. Healing of the epidermophytosis led to considerable
improvement of the main disease. These themes of the in-
teraction between the epidermis and potentially infective
organisms with the functions of the underlying vascula-
ture and lymphatic drainage in the dermis continues to
draw attention to the well-being of the epidermis and the
fact that this can be induced by washing and emollients.
In the exploration of the inflammatory responses of the
epidermis in lymphoedema, one can now recognise that
bacteria have several roles to play in the generation of in-
flammatory responses of which superantigens and shock
proteins are only part of the story. The damaged epidermis
of mice is known to produce antimicrobial peptides such
as LL-37-enhanced by interferon gamma (IFN-γ), which
have been shown to influence the survival and multiplica-
tion of streptococcus A in wounds [73], which remains the
commonest cause of dermal and hypodermal infection in
lymphoedema.
While Dermatologists have recognised a streptococcal
pretibial cellulitis as a marker of fungal infection between
the toes, the profession of lymphologists have long recog-
nised it as a marker of lymphoedema. The focus of today's
management is restoring barrier function of the epidermis
by washing and emollients.
When examining the microcirculation of the skin or nail
bed in persons infected with Candida or ringworm fungi,
one notes considerable hypertrophy of the blood vessels
supplying the epidermis. Frequently there are microhaem-
orrhages and there are completely irreversible thromboses
of the papillary vasculature. Since there is a correlation be-
tween the structure of keratin and its invasion by dermat-
ophytes and yeasts [74], and since keratin formation
normally depends on healthy epidermal capillary rela-
tionships, there is a tendency for fungal infection to en-
courage the kind of disturbances in both keratin and
blood vessels which provide an ideal environment for
their growth.
The Use of Antibiotics
The organisms that invade the skin and cause dermal and
hypodermal infection exist on the skin or in the throat in
10–20% of persons and in most of these they are not caus-
ing any pathology. They have the potential to do great
harm, especially if they cross barriers, penetrate deeply
and are not destroyed by the host. Most recurrent inflam-
matory episodes (DLA) produce local inflammation of
the tissues but rarely cause their destruction nor shock or
death of the patient. The streptococcus that is most com-
monly blamed remains sensitive to penicillins, tetracy-
cline and several other antibiotics.
For most cases of DLA one can afford to await resolution
as a result of simple hygiene and use of emollients, but an-
tibiotics should be prescribed if improvement is notFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/4
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quickly apparent. Aggressive pathology such as blisters
and extreme pain with high fever out of proportion to the
local appearance may require intravenous antibiotics, and
rarely when cellulitis progresses to necrotizing fasciitis,
surgical debridement may be required. Prophylactic long-
term antibiotics (penicillin, 1–2 million units twice daily)
are often prescribed in the developed world where they
are fully affordable. Fortunately, the risks of antibiotic re-
sistance seem exceedingly low in the case of the organisms
responsible for bacterial inflammatory events of the DLA
kind.
Bandaging and Hosiery with Manual Lymphatic Drainage
Bandaging and hosiery with manual lymphatic drainage
are components of the gold standard management of lym-
phoedema. They are largely unavailable in the developing
world due to the lack of trained personnel and the cost of
materials. The pioneering efforts of Godoy in Brazil [75],
providing a simplified self-help massage system in a well-
illustrated booklet, should be more widely disseminated.
In the long term, all countries need this expertise, and for
the difficult case, there needs to be investment in the train-
ing of specialists. However, we are promoting in this pa-
per low cost, self-help.
Models of Lymphoedema Management
Patients and caregivers may find the concepts underlying
the management of lymphoedema somewhat complex.
To illustrate breathing and movement one may describe
the lion after a good meal and a prolonged sleep, who will
first yawn and take a deep breath, this will be followed by
stretching of shoulders and hips and back muscles, before
extending and moving the legs and paws. This sequence of
events ensures central emptying of the lymphatics and ve-
nous system before emptying the periphery.
To explain this sequence of events using another model
one may describe the process of emptying an auditorium
filled with people. First there must be an opening of the
doorways to the outside of the building and then the cor-
ridors should be emptied and the seats nearest the gang-
way similarly emptied before it is possible to exit rapidly
from the centre of a row of seats.
A model illustrating overload is the drain of a house that
is affected by a partial blockage and cracked pipes. Sewage
will seep away satisfactorily through low resistance path-
ways until there is a flash flood or the household enter-
tains an excess of guests. The system then becomes
overloaded and the failure of the drainage becomes pat-
ently manifest.
Conclusion
Bringing together the opinions currently expressed in the
literature concerned with lymphatic, venous and skin dis-
ease we conclude that low cost, self-help, management of
lymphoedema can be advocated. It is an amalgam of sys-
tems already in use, and although the evidence base is not
yet perfect, there have been many studies which give sup-
port to the management schemes described above. The in-
teraction of factors determining loss of barrier function
(to infective organisms, allergens and irritants) and the
chronic effects of venous hypertension with lymphatic
failure are amenable to therapy. Even the grossest of skin
hypertrophy can be reversed over time so that the handi-
cap caused by lymphatic filariasis can be eliminated as
well as the causative organism. It requires the co-opera-
tion of the patient and a concordance program that in-
cludes the patient's community, fits in with their lifestyle,
and assuages conflicting elements. This regime of therapy
is designed to do just that.
If this regime of therapy works, which includes elevation,
movement and skin care, it is likely to be of benefit in the
management of many other important diseases. This in-
cludes management of the skin of patients with AIDS, or
for the management of breaks in the surface continuity of
epithelium that are highly prevalent in the tropics and in
metabolic diseases such as diabetes mellitus or in vulner-
able groups such as the bedridden elderly.
It requires recognition that the grotesque changes that oc-
cur in the most severe cases of lymphoedema are not
merely a consequence of lymphatic failure alone. There is
in all cases a strong component of both venous and epi-
dermal failure, which responds to therapies specifically
aimed at the veins and epidermis.
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